UROLOGY JOURNAL, vol.15, no.1, pp.48-52, 2018 (SCI-Expanded)
Purpose: To investigate whether use of dutasteride, a 5-alpha reductase inhibitor, for at least four weeks preoperatively affected the blood loss during open prostatectomy (OP).